4//SEC Filing
Audentes Therapeutics, Inc. 4
Accession 0001209191-17-005996
CIK 0001628738operating
Filed
Jan 26, 7:00 PM ET
Accepted
Jan 27, 6:08 PM ET
Size
5.5 KB
Accession
0001209191-17-005996
Insider Transaction Report
Form 4
Nagler David
SVP, HR & Corp. Affairs
Transactions
- Award
Stock Option (right to buy)
2017-01-25+50,000→ 50,000 totalExercise: $15.26Exp: 2027-01-25→ Common Stock (50,000 underlying)
Footnotes (1)
- [F1]The option vests as to 2.0833% of the total shares monthly, beginning February 25, 2017, with 100% of the total shares vested and exercisable on January 25, 2021, subject to the reporting person's provision of service to the issuer on each vesting date.
Documents
Issuer
Audentes Therapeutics, Inc.
CIK 0001628738
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001628738
Filing Metadata
- Form type
- 4
- Filed
- Jan 26, 7:00 PM ET
- Accepted
- Jan 27, 6:08 PM ET
- Size
- 5.5 KB